SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 206 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $352 | -43.9% | 200 | 0.0% | 0.00% | – |
Q4 2022 | $628 | -68.6% | 200 | 0.0% | 0.00% | – |
Q2 2021 | $2,000 | -33.3% | 200 | 0.0% | 0.00% | – |
Q4 2020 | $3,000 | +50.0% | 200 | 0.0% | 0.00% | – |
Q3 2020 | $2,000 | +100.0% | 200 | 0.0% | 0.00% | – |
Q1 2020 | $1,000 | -98.5% | 200 | -96.8% | 0.00% | -100.0% |
Q3 2019 | $67,000 | 0.0% | 6,267 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $67,000 | +11.7% | 6,267 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $60,000 | -18.9% | 6,267 | -2.9% | 0.00% | -33.3% |
Q4 2018 | $74,000 | -35.7% | 6,451 | -5.0% | 0.01% | -25.0% |
Q3 2018 | $115,000 | +15.0% | 6,789 | -7.7% | 0.01% | 0.0% |
Q2 2018 | $100,000 | -16.0% | 7,358 | +17.0% | 0.01% | -20.0% |
Q1 2018 | $119,000 | +65.3% | 6,288 | +42.8% | 0.01% | +66.7% |
Q4 2017 | $72,000 | +1340.0% | 4,403 | +1367.7% | 0.01% | +500.0% |
Q3 2017 | $5,000 | +66.7% | 300 | 0.0% | 0.00% | – |
Q2 2017 | $3,000 | +50.0% | 300 | 0.0% | 0.00% | – |
Q1 2017 | $2,000 | +100.0% | 300 | 0.0% | 0.00% | – |
Q3 2016 | $1,000 | -50.0% | 300 | 0.0% | 0.00% | – |
Q2 2016 | $2,000 | – | 300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |